Infection and infectious diseases, Guidance

Applied filters

Care Setting (6)
- Dentistry (2)
- Neonates (3)
- Trusts (1)
Guidance (153)
- Administering (3)
- Aseptic services (5)
- COVID-19 Treatments (2)
- Cautions and contraindications (2)
- Formulation (2)
- Interactions (1)
- Intrathecal medicines (5)
- Patient Group Directions (3)
- Preparing (2)
- Prescribing (1)
- Safety in Breastfeeding (132)
- Safety in Pregnancy (2)
- Temperature management (18)
  - Stability outside the fridge (18)
Medicine (147)
- Aciclovir (3)
- Amantadine (1)
- Amikacin (3)
- Amorolfine (1)
- Amoxicillin (2)
- Amphotericin B (1)
- Ampicillin (2)
- Anakinra (1)
- Anidulafungin (1)
- Atorvastatin (1)
- Atovaquone (1)
- Azithromycin (3)
- Aztreonam (2)
- Benzyl benzoate (1)
- Benzylpenicillin (3)
- Caspofungin (1)
- Cefaclor (2)
- Cefadroxil (2)
- Cefalexin (2)
- Cefixime (2)
- Cefotaxime (2)
- Cefpodoxime (2)
- Cefradine (2)
- Ceftazidime (2)
- Ceftriaxone (2)
- Cefuroxime (2)
- Chloramphenicol (3)
- Chloroquine (1)
- Cidofovir (2)
- Ciprofloxacin (3)
- Clarithromycin (2)
- Clindamycin (2)
- Clofazimine (1)
- Clotrimazole (3)
- Co-amoxiclav (2)
- Co-fluampicil (2)
- Co-trimoxazole (1)
- Colistimethate (3)
- Dapsone (1)
- Daptomycin (2)
- Demeclocycline (2)
- Diloxanide (1)
- Dimeticone (1)
- Doxycycline (2)
- Econazole (3)
- Entecavir (2)
- Erythromycin (2)
- Ethambutol (2)
- Fidaxomicin (1)
- Flucloxacillin (2)
- Fluconazole (1)
- Fluorescein (1)
- Fluvastatin (1)
- Ganciclovir (3)
- Gentamicin (4)
- Griseofulvin (2)
- Hydroxychloroquine (1)
- Imipenem + Cilastatin (2)
- Inosine acedoben dimepranol (2)
- Interferon alfa (2)
- Interferon beta-1a (1)
- Isoniazid (2)
- Itraconazole (1)
- Ivermectin (2)
- Ketoconazole (3)
- Lamivudine (3)
- Levofloxacin (3)
- Linezolid (2)
- Lopinavir + Ritonavir (2)
- Lymecycline (2)
- Malathion (1)
- Mebendazole (2)
- Mefloquine (1)
- Meningococcal groups A + C + W135 + Y vaccine (1)
- Mepacrine (1)
- Meropenem (2)
- Metronidazole (2)
- Miconazole (4)
- Minocycline (2)
- Moxifloxacin (3)
- Mupirocin (1)
- Nalidixic acid (2)
- Neomycin (3)
- Niclosamide (2)
- Nitrofurantoin (2)
- Norfloxacin (2)
- Nystatin (2)
- Ofloxacin (3)
- Oseltamivir (2)
- Oxytetracycline (2)
- Peginterferon alfa-2a (2)
- Peginterferon alfa-2b (1)
- Peginterferon beta-1a (1)
- Phenoxymethylpenicillin (2)
- Piperacillin + Tazobactam (2)
- Pivmecillinam (2)
- Polymyxin B + Bacitracin (1)
- Posaconazole (1)
- Pravastatin (1)
- Praziquantel (2)
- Primaquine (1)
- Proguanil (1)
- Pyrazinamide (1)
- Pyrimethamine + Sulfadoxine (1)
- Quinine (1)
- Raltegravir (2)
- Ribavirin (2)
- Rifampicin (2)
- Rifaximin (2)
- Rilpivirine (2)
- Ritonavir (2)
- Rosuvastatin (1)
- Salicylic acid (1)
- Sarilumab (1)
- Simvastatin (1)
- Sodium fusidate (2)
- Streptomycin (3)
- Sulfadiazine (1)
- Teicoplanin (2)
- Temocillin (2)
- Tenofovir (3)
- Tenofovir disoproxil (1)
- Terbinafine (2)
- Tetracycline (2)
- Tinidazole (1)
- Tobramycin (3)
- Tocilizumab (2)
- Trimethoprim (2)
- Valaciclovir (2)
- Valganciclovir (1)
- Vancomycin (4)
- Voriconazole (1)
- Zanamivir (2)
Medicines planning (43)
- New Medicines (14)
  - CCG commissioned new medicines (5)
  - NHS England commissioned new medicines (9)
  - Pre-registration new medicines (UK/EU) (2)
- Patent expiries (35)
Publications (3)
- Templates (3)
Specialty (153)
- Allergy and immunology (2)
- Cancers (2)
- Ear, nose and throat disorders (5)
- Endocrine system disorders (1)
- Eyes and vision (11)
- Gastrointestinal disorders (1)
- Infection and infectious diseases (153)
- Musculo-skeletal disorders (4)
- Neurological disorders (2)
- Obstetrics and gynaecology (4)
- Renal and urologic disorders (3)
- Sexual health (1)
- Skin disorders (16)

Trimethoprim for Urinary Tract Infection (UTI)

19 January 2023SPS PGD template for the supply of trimethoprim tablets for the treatment of Urinary Tract Infection (UTI).

Nitrofurantoin for Urinary Tract Infection (UTI)

19 January 2023SPS PGD template for the supply of nitrofurantoin capsules/tablets for the treatment of Urinary Tract Infection (UTI).

Gentamicin products: information for supporting intrathecal risk assessment

11 August 2022Gentamicin products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Colistimethate Sodium products: information for supporting intrathecal risk assessment

11 August 2022Colistimethate products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Fluorescein products: information for supporting intrathecal risk assessment

11 August 2022Fluorescein products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Vancomycin products: information for supporting intrathecal risk assessment

11 August 2022Vancomycin products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Amikacin products: information for supporting intrathecal risk assessment

11 August 2022Amikacin products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Assessing if individuals with hydrocephalus shunts require antibiotic prophylaxis for dental procedures

7 April 2022Factors to consider when deciding if the risk of shunt infections due to transient bacteraemia from invasive dental procedures warrants non-routine prophylaxis.

Urinary tract infection: treatment during pregnancy

6 January 2022Signposting evidence-based information on the treatment of urinary tract infection in pregnancy

Thrush or vaginal candida: treatment during pregnancy

6 January 2022Signposting evidence-based information on the treatment of thrush or vaginal Candida in pregnancy

SPS - Specialist Pharmacy Service

NHS